Subscribe
shutterstock_676034119_testing
Testing / Shutterstock.com
10 March 2022AmericasMuireann Bolger

FujiFilm sues Butterfly Network over ultrasound patents

A subsidiary of Tokyo-based FujiFilm has announced that it has filed a patent infringement lawsuit against ultrasound machine maker Butterfly Network.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.

More on this story

Asia-Pacific
Fujifilm makes $800m acquisition
5 April 2018   Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.
Asia-Pacific
Fujifilm signs influenza drug licensing deal
22 June 2016   Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB